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Abstract
Coronavirus disease 2019 (COVID-19) has become a global pandemic in a short period, where a tragically large number of 
human lives being lost. It is an infectious pandemic that recently infected more than two hundred countries in the world. Many 
potential treatments have been introduced, which are considered potent antiviral drugs and commonly reported as herbal 
or traditional and medicinal treatments. A variety of bioactive metabolites extracts from natural herbal have been reported 
for coronaviruses with some effective results. Food and Drug Administration (FDA) has approved numerous drugs to be 
introduced against COVID-19, which commercially available as antiviral drugs and vaccines. In this study, a comprehensive 
review is discussed on the potential antiviral remedies based on natural and synthetic drugs. This review highlighted the 
potential remedies of COVID-19 which successfully applied to patients with high cytopathic inhibition potency for cell-to-
cell spread and replication of coronavirus.
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1 Introduction
The emergence of recent coronavirus disease 2019 (COVID-
19) has become an alarming issue and shaken the whole 
world. The new pathogenic strain [1] produced by corona-
virus has infected millions of people worldwide that led to 
massive death since December 2019 [2]. COVID-19 was 
first identified in Wuhan, China from an unknown source 
of coronavirus, which gradually spread to the whole world 
[3–7] and tragically affected human life. Severe acute res-
piratory syndrome coronavirus 2 (SARS-CoV-2) is the 
virus that causes COVID-19 in humans and animals [8–14]. 
COVID-19 has a similarity with the earlier reported disease 
called severe acute respiratory syndrome (SARS) caused 
by severe acute respiratory syndrome coronavirus (SARS-
CoV), regarding their symptoms i.e. cough, fatigue, fever, 
and lower respiratory sign [15–17]. The current pandemic 
has compelled the researchers to explore new effective drugs 
against COVID-19.
SARS-CoV-2 is structurally similar to other coronavirus 
and is only differentiated by the prominent spike of proteins 
[18]. Coronaviruses belong to positive single-strand long 
RNA viruses [19, 20] with numerous structural proteins i.e. 
envelope (E), spike (S) [21], membrane (M), nucleocap-
sid (N) proteins contributing or assisting virus for replica-
tion [22] and entry in the host [23]. Both SARS-CoV and 
SARS-CoV-2 have common angiotensin-converting enzyme 
2 (ACE2) used as a receptor that is responsible for the res-
piratory syndrome. Startlingly, the spike-glycoprotein plays 
an important role for a strong guest host binding with the 
targets receptor [24]. The Mpro enzyme contributed to the 
viral replication of coronavirus [25]. The viral proteases 
(PL-pro and 3-CL pro) are contributed to the cleavage of 
replicate polyproteins, significant for viral replication [26]. 
SARS-CoV-2 can also enter into the host via endosomes at 
low pH, which can be controlled by increasing pH [27]. A 
comprehensive illustration of the SARS-CoV-2 structure, 
replication cycle and immune system response is depicted 
in (Fig. 1) [28, 29].
The phylogenetic tree of coronaviruses consists of four 
types i.e. α-coronavirus, β-coronavirus, γ-coronavirus, 
δ-coronavirus [30]. Phylogeny and genomic analysis 
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